More than 300 news organizations, including CBS and Forbes, quoted Abt’s Lauren Olsho explaining the benefits of our PROTECT study for the CDC, which gathers and tests nasal swabs weekly from children, regardless of whether they had COVID-19 symptoms. “Without regular weekly testing you will miss many infections, particularly for kids, who often have mild symptoms,” said Olsho, the study’s principal investigator. Other pediatric vaccine studies captured only symptomatic cases, and with more home testing, studies like Abt’s are needed for a comprehensive view of vaccine effectiveness, she noted.
Read More
COVID-19 in North America
National Association of Conservation Districts (NACD) Summer Meeting
We’re headed to Grand Rapids to showcase conservation tools rooted in results and ready for the field.
Abt Global Wins Seat on CMS RMADA 3 Contract Vehicle
Abt Global has been awarded a seat on the Centers for Medicare & Medicaid Services’ (CMS) Research, Measurement, Assessment, Design, and Analysis 3 contract vehicle, known as RMADA 3.
What Makes Rural Health Hubs Work? An Evaluation Framework for States
Abt’s framework for evaluating rural health hubs and measuring access, coordination, population health, and system resilience.
Healthy Military Families Undergird National Readiness
The only DoW-wide longitudinal study on U.S. military family health has generated vital evidence to inform programs, policies, and support services critical to family stability and force readiness.